Advertisement

Amino Acid Versus Glucose Dialysis in Children on CAPD

  • J. W. Balfe
  • R. M. Hanning
  • S. H. Zlotkin

Summary

Nineteen children on CAPD have undergone short-term trials wherein amino acids have substituted for dextrose as osmotic agents in peritoneal dialysis fluid. Amino acid concentrations of 1.1% and 2.0% had osmolal concentrations comparable to 2.5% and 4.25% dextrose. Maximal absorption of amino acids and dextrose occurred within 1 hour after instillation. Fluid, urea, and creatinine removal were satisfactory with the modified dialysis solution and no adverse effects were noted. Long-term trials are recommended.

Keywords

Peritoneal Dialysis Continuous Ambulatory Peritoneal Dialysis Dialysis Solution Osmotic Agent Peritoneal Dialysis Fluid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stefanidis CJ, Hewitt IK, and Balfe JW: Growth in children receiving continuous ambulatory peritoneal dialysis. J Pediatr 102: 681, 1983PubMedCrossRefGoogle Scholar
  2. 2.
    Hsu AC, Kooh SW, Fraser D, Cumming WA, and Fornasier VL: Renal osteodystrophy in children with chronic renal failure: An unexpectedly common and incapacitating complication. Pediatrics 70: 742, 1982PubMedGoogle Scholar
  3. 3.
    Holliday MA, and Chantier C: Metabolic and nutritional factors in children with renal insufficiency. Kidney Int 14: 306, 1978PubMedCrossRefGoogle Scholar
  4. 4.
    Canadian Renal Failure Register: 1982 Report. Kidney Foundation of Canada.Google Scholar
  5. 5.
    Salusky IB, Fine RN, Nelson P, Blumenkrantz MJ, and Kopple JD: Nutritional status of children undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr 38: 599, 1983PubMedGoogle Scholar
  6. 6.
    Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, and Coburn JW: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 19: 564, 1981PubMedCrossRefGoogle Scholar
  7. 7.
    Balfe JW, Vigneux A, Willumsen J, and Hardy BE: The use of CAPD in the treatment of children with end stage renal disease. Peritoneal Dial Bull 1: 35, 1981Google Scholar
  8. 8.
    Potter DE, McDaid TK, McHenry K, and Mar H: Continuous ambulatory peritoneal dialysis (CAPD) in children. Trans Am Soc Artif Intern Organs 27: 64, 1981PubMedGoogle Scholar
  9. 9.
    Moncrief J, Pyle W, Simon P, and Popovich R: Hypertriglyceridemia, diabetes mellitus and insulin administration in patients undergoing CAPD. In Moncrief JW, and Popovich (Eds), CAPD update. New York: Masson Publishing, 1981, p 143Google Scholar
  10. 10.
    Kopple JD, and Blumenkrantz MJ: Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 24 (Suppl 16): S295, 1983Google Scholar
  11. 11.
    Katirzoglou A, Oreopoulos DG, Husdan H, Leung M, Ogilvie R, and Dombros N: Reappraisal of protein losses in patients undergoing CAPD. Nephron 26: 230, 1980CrossRefGoogle Scholar
  12. 12.
    Rubin J, Nolph KD, Arfania D, Prowant B, Fruto L, Brown P, and Moore H: Protein losses in continuous ambulatory peritoneal dialysis. Nephron 28: 218, 1981CrossRefGoogle Scholar
  13. 13.
    Dombros N, Oren A, Marliss EB, Anderson GH, Stein AN, Khanna R, Petit J, Brandes L, Rodella H, Leibel BS, and Oreopoulos DE: Plasma amino acid profiles and amino acid losses in patients undergoing CAPD. Peritoneal Dial Bull 2: 27, 1982Google Scholar
  14. 14.
    Giordano C, DeSanto NG, Capodicasa G, DiLeo VA, Diserafi A, Cirillo D, Esposito R, Damiano M, and Buonadon L: Amino acid losses during CAPD in children. Int J Pediatr Nephrol 2: 85, 1981PubMedGoogle Scholar
  15. 15.
    Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, and Coburn JW: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 36: 395, 1982PubMedGoogle Scholar
  16. 16.
    Wu G: Osmotic agents for peritoneal dialysis solutions. Peritoneal Dial Bull 2: 151, 1982Google Scholar
  17. 17.
    Oreopoulos DG, Marliss E, and Anderson GH: Nutritional aspects of CAPD and the potential use of amino acid containing dialysis solutions. Peritoneal Dial Bull 3 (Suppl): S10, 1983Google Scholar
  18. 18.
    Hanning RM, Balfe JW, and Zlotkin SH. The efficacy of amino acid vs glucose dialysis in children on continuous ambulatory peritoneal dialysis Pediatr Res (Abstract) 17: 1590, 1983Google Scholar
  19. 19.
    Balfe JW, Zlotkin SH, and Hanning RM: Amino acid vs glucose dialysis in children on continuous ambulatory peritoneal dialysis. Peritoneal Dial Bull 4 (Suppl): S3, 1984Google Scholar
  20. 20.
    Gjessing J: Addition of acids to peritoneal dialysis fluid. Lancet 2: 812, 1968PubMedCrossRefGoogle Scholar
  21. 21.
    Kobayashi K, Manji T, Hiramatsu S, Maeda K, and Uemura J: Nitrogen metabolism in patients on peritoneal dialysis. Contrib Nephrol 17: 93, 1979PubMedGoogle Scholar
  22. 22.
    Jackson M, Thomas D, Talbot S, and Lee H: Prevention of amino acid losses during peritoneal dialysis. Postgrad Med J 55: 533, 1979PubMedCrossRefGoogle Scholar
  23. 23.
    Oreopoulos DG, Crassweller P, Katirtzoglou A, Ogilvie R, Zellerman G, Rodella H, and Vas SI: Amino acids as an osmotic agent (instead of glucose) in continuous ambulatory peritoneal dialysis. In Le-grain M (Ed), Continuous ambulatory peritoneal dialysis: Proceedings of an international symposium, Paris, 1979. Amsterdam: Excerpta Medica, 1980, p 335Google Scholar
  24. 24.
    Oreopoulos DG, Balfe JW, Khanna R, Crassweller P, Gotloib L, Rodella H, Zellerman G, Brandes L, McReady W, Ogilvie R, and Husdan H: Further experience with the use of amino acid containing dialysate (amino-dianeal) in peritoneal dialysis. In MoncriefJW, and Popovich RP (Eds), CAPD update: continuous ambulatory peritoneal dialysis. New York: Masson Publishing, 1981, p 109Google Scholar
  25. 25.
    Williams PF, Marliss EB, Anderson GH, Oren A, Stein AN, Khanna R, Petitt J, Brandes L, Rodella H, Mupas L, Dombros N, and Oreopoulos DG: Amino acid absorption following intraperitoneal administration in CAPD patients. Peritoneal Dial Bull 2: 124, 1982Google Scholar
  26. 26.
    Alvestrand A, Fürst P, and Bergström J: Plasma and muscle free amino acids in uremia: Influence of nutrition with amino acids. Clin Nephrol 18: 297, 1982PubMedGoogle Scholar
  27. 27.
    Broyer M, Jean G, Dartois AM, and Kleinknecht C: Plasma and muscle free amino acids in children at the early stages of renal failure. Am J Clin Nutr 33: 1396, 1980PubMedGoogle Scholar
  28. 28.
    Alvestrand A, Fürst P, and Bergström J: Intracellular amino acids in uremia. Kidney Int 24 (Suppl 16): 9, 1983Google Scholar
  29. 29.
    Alvestrand A, Ahlberg M, Fürst P, and Bergström J: Clinical results of long-term treatment with a low protein diet and a new amino acid preparation in patients with chronic uremia. Clin Nephrol 19: 67, 1983PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • J. W. Balfe
    • 1
  • R. M. Hanning
    • 1
  • S. H. Zlotkin
    • 1
  1. 1.The Hospital for Sick ChildrenUniversity of Toronto and the Research InstituteTorontoCanada

Personalised recommendations